Evaluation of composite collagen/hydroxy-apatite implantation and nerve growth factor (NGF) delivery on new bone in growth

In this study, a bio-ertittciel bioresorbable composite consisting of a polymer of coffagen/hydroxy-apatite (Col/Hap) enriched with neurotropin - nerve growth factor (NGF), was implanted into the femurs of 73 male Wistar rats, weighing 100-125 g. Implants were left in place for different times. Controls were as foffows: a) contralatera/ femur without any implants; and b) contralateral femur implanted with composite without NGF factor. Therats were euthanizedafter 1, 10 and 30 days and the implant sites and explants were examined clinically, histologicaffy, by scanning electron microscopy and histomorpho metricaffy. The results show stimulated periosteal and enciocorticet woven and lameffar bone formation, which yielded increases in bone mass and decreases in bone marrow. The NGF treatment had greater effects in the femur shafts of older male rats than in younger ones. Additionaffy, we found that NGF increased remodeling activity in the intrecorticet region and induced an increase of intrecorticel cavity numberand area by the end of the study. Since no similar studies appear to have been carried out, it is difficult to correlate our findings with other studies where neurogenic factors are delivered by complex polymer composites. We believe that this proposed system has great advantages in tissue engineering and is very suitable as a biomaterial for fiffing irregular defects in orthopaedic and maxillo-facial surgery, bone replacement and fixation, and as a drug delivery device. edotoxin tested; neurobiological tests; neurofilament outgrowth observed at 30 ng/ml; cell culture: free of bacteria, yeasts, moulds and mycoplasma; preparation: by gel filtration and ion-exchange chromatography, sterilized by 0.2 mm-filtration and lyophilized (100 mg) from 1 ml of 5 mM PBS, pH 6.8. Solubility (0.1 mq/rnl H20) clear, colorless. Implants were left in place for different times, after which termination was performed by cardiac perfusion with Karnovsky's fixative. The bone was dissected to reveal the implant site and subsequently remained in Karnovsky's fixative for another 5 days. One femur from each animal was examined in the scanning electron microscope (SEM). Quantitative evaluations were carried out using a digitizing image analyzing system (DIAS). Total cross-sectional area (T.Ar), marrow area, cortical width, periosteal new bone area, and osteoid surface (O.Pm) were recorded. These parameters were used to calculate the total bone area (TB.Ar), cortical bone area (Ct.Ar), percent cortical area (%Ct.Ar), percent osteoid perimeter (O.Pm/B.Pm), mineral apposition rate (MAR), and bone formation rate per unit of bone surface (BFR/B.Pm). The porosity was defined as intracortical cavities with diameter >30~lm. Intracortical cavity area and cortical area were used to calculate the percent porosity area. Forming osteon number (FON) was the sum of single and double labeled surfaces. Forming osteon number, resorption cavity number, and porosity number were used to calculate the forming osteon density (%RCN) and the ratio of the forming osteon number and resorption number (FON/RCN). Results are presented as mean ± SD. The differences within groups were evaluated statistically using one-way analysis of variance (ANOVA). P>0.05 was considered significant.

[1]  K. Kataoka,et al.  Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.

[2]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.

[3]  P. Lehenkari,et al.  Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors. , 2001, Endocrinology.

[4]  R. Scandurra,et al.  Genetic potential of interfacial guided osteogenesis in implant devices. , 2000, Dental materials journal.

[5]  P. Bergmann,et al.  Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders?☆ , 2000, Peptides.

[6]  Y. Ma,et al.  Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain. , 1999, Bone.

[7]  K. Smans,et al.  Neuro-hormonal control of bone metabolism: vasoactive intestinal peptide stimulates alkaline phosphatase activity and mRNA expression in mouse calvarial osteoblasts as well as calcium accumulation mineralized bone nodules , 1999, Regulatory Peptides.

[8]  B. Kundu,et al.  Role of polypeptides in the treatment and diagnosis of osteoporosis 1 CDRI communication No. 5879. 1 , 1999, Peptides.

[9]  Y. Shikinami,et al.  Bioresorbable devices made of forged composites of hydroxyapatite (HA) particles and poly-L-lactide (PLLA): Part I. Basic characteristics. , 1999, Biomaterials.

[10]  D. Bakoš,et al.  Hydroxyapatite-collagen-hyaluronic acid composite. , 1999, Biomaterials.

[11]  X. D. Zhu,et al.  Tissue response to nano-hydroxyapatite/collagen composite implants in marrow cavity. , 1998, Journal of biomedical materials research.

[12]  C. Berndt,et al.  Variability of hydroxyapatite-coated dental implants. , 1998, The International journal of oral & maxillofacial implants.

[13]  A. Reddi,et al.  Role of morphogenetic proteins in skeletal tissue engineering and regeneration , 1998, Nature Biotechnology.

[14]  S. Lee,et al.  Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[15]  J. Hirsch,et al.  Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. , 1998, European journal of oral sciences.

[16]  M. Lind,et al.  Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. , 1998, Acta orthopaedica Scandinavica. Supplementum.

[17]  S. Bonini,et al.  The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases , 1997, Allergy.

[18]  L. Johansson,et al.  Cystatin C, and inhibitor of bone resorption produced by osteoblasts. , 1997, Acta physiologica Scandinavica.

[19]  A. Reddi,et al.  Tissue engineering, morphogenesis, and regeneration of the periodontal tissues by bone morphogenetic proteins. , 1997, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[20]  M. Urist,et al.  The use of a coral composite implant containing bone morphogenetic protein to repair a segmental tibial defect in sheep , 1997, International Orthopaedics.

[21]  S. Chevalier,et al.  Nerve growth factor is involved in the supportive effect by bone marrow--derived stromal cells of the factor-dependent human cell line UT-7. , 1996, Blood.

[22]  M. Lind,et al.  Growth factors: possible new clinical tools. A review. , 1996, Acta orthopaedica Scandinavica.

[23]  W S Pietrzak,et al.  Bioresorbable implants--practical considerations. , 1996, Bone.

[24]  U. Lerner Regulation of bone metabolism by the kallikrein-kinin system, the coagulation cascade, and the acute-phase reactants. , 1994, Oral surgery, oral medicine, and oral pathology.

[25]  M. Nishida,et al.  Histological changes of implanted collagen material during bone induction. , 1994, Journal of biomedical materials research.

[26]  T. Habu,et al.  Changes in Protein Secretion by Rat Submandibular Glands in Response to Isoproterenol, a-Methylnoradrenaline, and Clonidine during Post-natal Development , 1990, Journal of dental research.

[27]  M. Schultzberg,et al.  Substance P- and CGRP-immunoreactive nerves in bone , 1988, Peptides.

[28]  I. J. Singh,et al.  Effect of surgical sympathectomy on bone remodeling at rat incisor and molar root sockets , 1987, The Anatomical record.

[29]  E. Shooter,et al.  The biology and mechanism of action of nerve growth factor. , 1982, Annual review of biochemistry.

[30]  G. H. Nancollas,et al.  Crystallization of calcium phosphates. A constant composition study , 1980 .